281 related articles for article (PubMed ID: 19356608)
1. Chimeric hepatitis B and C viruses envelope proteins can form subviral particles: implications for the design of new vaccine strategies.
Patient R; Hourioux C; Vaudin P; Pagès JC; Roingeard P
N Biotechnol; 2009 Apr; 25(4):226-34. PubMed ID: 19356608
[TBL] [Abstract][Full Text] [Related]
2. Chimeric hepatitis B virus/hepatitis C virus envelope proteins elicit broadly neutralizing antibodies and constitute a potential bivalent prophylactic vaccine.
Beaumont E; Patient R; Hourioux C; Dimier-Poisson I; Roingeard P
Hepatology; 2013 Apr; 57(4):1303-13. PubMed ID: 23150224
[TBL] [Abstract][Full Text] [Related]
3. Immunizations with chimeric hepatitis B virus-like particles to induce potential anti-hepatitis C virus neutralizing antibodies.
Vietheer PT; Boo I; Drummer HE; Netter HJ
Antivir Ther; 2007; 12(4):477-87. PubMed ID: 17668556
[TBL] [Abstract][Full Text] [Related]
4. Presentation of the hydrophilic domains of hepatitis C viral E2 envelope glycoprotein on hepatitis B surface antigen particles.
Lee IH; Kim CH; Ryu WS
J Med Virol; 1996 Oct; 50(2):145-51. PubMed ID: 8915880
[TBL] [Abstract][Full Text] [Related]
5. Analysis of the cytosolic domains of the hepatitis B virus envelope proteins for their function in viral particle assembly and infectivity.
Blanchet M; Sureau C
J Virol; 2006 Dec; 80(24):11935-45. PubMed ID: 17020942
[TBL] [Abstract][Full Text] [Related]
6. Immunoreactivity of HCV/HBV epitopes displayed in an epitope-presenting system.
Chen Y; Xiong X; Liu X; Li J; Wen Y; Chen Y; Dai Q; Cao Z; Yu W
Mol Immunol; 2006 Feb; 43(5):436-42. PubMed ID: 16337486
[TBL] [Abstract][Full Text] [Related]
7. A unique amino acid substitution, L215Q, in the hepatitis B virus small envelope protein of a genotype F isolate that inhibits secretion of hepatitis B virus subviral particles.
Araujo NM; Vianna CO; Soares CC; Gomes SA
Intervirology; 2008; 51(2):81-6. PubMed ID: 18434744
[TBL] [Abstract][Full Text] [Related]
8. Effect of mutations in the small envelope protein of hepatitis B virus on assembly and secretion of hepatitis delta virus.
Jenna S; Sureau C
Virology; 1998 Nov; 251(1):176-86. PubMed ID: 9813213
[TBL] [Abstract][Full Text] [Related]
9. Chimeric hepatitis B virus (HBV)/hepatitis C virus (HCV) subviral envelope particles induce efficient anti-HCV antibody production in animals pre-immunized with HBV vaccine.
Beaumont E; Roingeard P
Vaccine; 2015 Feb; 33(8):973-6. PubMed ID: 25596457
[TBL] [Abstract][Full Text] [Related]
10. Both pre-S1 and S domains of hepatitis B virus envelope proteins interact with the core particle.
Poisson F; Severac A; Hourioux C; Goudeau A; Roingeard P
Virology; 1997 Feb; 228(1):115-20. PubMed ID: 9024817
[TBL] [Abstract][Full Text] [Related]
11. Structural and biological properties of Cucumber mosaic virus particles carrying hepatitis C virus-derived epitopes.
Nuzzaci M; Bochicchio I; De Stradis A; Vitti A; Natilla A; Piazzolla P; Tamburro AM
J Virol Methods; 2009 Feb; 155(2):118-21. PubMed ID: 18992770
[TBL] [Abstract][Full Text] [Related]
12. Characterization of pseudotype VSV possessing HCV envelope proteins.
Matsuura Y; Tani H; Suzuki K; Kimura-Someya T; Suzuki R; Aizaki H; Ishii K; Moriishi K; Robison CS; Whitt MA; Miyamura T
Virology; 2001 Aug; 286(2):263-75. PubMed ID: 11485395
[TBL] [Abstract][Full Text] [Related]
13. High immunogenicity of a hydrophilic component of the hepatitis B virus preS1 sequence exposed on the surface of three virus-like particle carriers.
Skrastina D; Bulavaite A; Sominskaya I; Kovalevska L; Ose V; Priede D; Pumpens P; Sasnauskas K
Vaccine; 2008 Apr; 26(16):1972-81. PubMed ID: 18343539
[TBL] [Abstract][Full Text] [Related]
14. Role of the antigenic loop of the hepatitis B virus envelope proteins in infectivity of hepatitis delta virus.
Jaoudé GA; Sureau C
J Virol; 2005 Aug; 79(16):10460-6. PubMed ID: 16051838
[TBL] [Abstract][Full Text] [Related]
15. Hepatitis C Virus Envelope Glycoprotein E1 Forms Trimers at the Surface of the Virion.
Falson P; Bartosch B; Alsaleh K; Tews BA; Loquet A; Ciczora Y; Riva L; Montigny C; Montpellier C; Duverlie G; Pécheur EI; le Maire M; Cosset FL; Dubuisson J; Penin F
J Virol; 2015 Oct; 89(20):10333-46. PubMed ID: 26246575
[TBL] [Abstract][Full Text] [Related]
16. Expression and structural properties of a chimeric protein based on the ectodomains of E1 and E2 hepatitis C virus envelope glycoproteins.
Tello D; Rodríguez-Rodríguez M; Yélamos B; Gómez-Gutiérrez J; Ortega S; Pacheco B; Peterson DL; Gavilanes F
Protein Expr Purif; 2010 Jun; 71(2):123-31. PubMed ID: 20176110
[TBL] [Abstract][Full Text] [Related]
17. Envelopment of the hepatitis B virus nucleocapsid.
Bruss V
Virus Res; 2004 Dec; 106(2):199-209. PubMed ID: 15567498
[TBL] [Abstract][Full Text] [Related]
18. Hepatitis B virus subviral envelope particle morphogenesis and intracellular trafficking.
Patient R; Hourioux C; Sizaret PY; Trassard S; Sureau C; Roingeard P
J Virol; 2007 Apr; 81(8):3842-51. PubMed ID: 17267490
[TBL] [Abstract][Full Text] [Related]
19. Evidence that N-linked glycosylation is necessary for hepatitis B virus secretion.
Lu X; Mehta A; Dwek R; Butters T; Block T
Virology; 1995 Nov; 213(2):660-5. PubMed ID: 7491790
[TBL] [Abstract][Full Text] [Related]
20. In vitro characterization of viral fitness of therapy-resistant hepatitis B variants.
Villet S; Billioud G; Pichoud C; Lucifora J; Hantz O; Sureau C; Dény P; Zoulim F
Gastroenterology; 2009 Jan; 136(1):168-176.e2. PubMed ID: 18996386
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]